Clinical trials market now witnesses a paradigm shift. Naïve heterogeneous patient populations in the developing nations are opening up new avenues for the clinical trials market. Developing countries also offer faster means; which is triggering major pharmaceutical companies to direct their investment in these regions. Apart from this, stringent regulations and tight R&D budgets in the pharma-biotech industry are also forcing companies to move to east. This scenario has further boosted the alliances between the pharma-biotech companies and the clinical research organizations, with the latter accounting for major chunk of the trials conducted.
Browse All : Market Research ReportToday, emerging countries account for the largest share of the phase II/III (prime stages) clinical trials conducted globally with major focus on oncology, Alzheimer’s, metabolic, and cardiovascular diseases. Support from the respective government bodies is one of the major factors affecting the Clinical trials market. Clinical trials sponsored by the industry have a much higher share in the market as compared to government organizations.
North America includes the U.S. and Canada; together both the countries have reported to have the largest number of clinical trials conducted globally. In the European region, Germany heads the largest number of clinical trials, the country was reported to have conducted 734 trials for 2010 in Western Europe while Poland accounted for the largest number of clinical trials in Eastern Europe with total number of 263 clinical trials for 2010.
Asia is one of the fastest growing markets for global clinical trials. The countries taking lead in this market are India, China, South Korea, and Singapore. The major reasons for this market to have high potential are its huge and diverse population with diseases that are present in both - the developed and under developed countries. Hence, different types of trials can be conducted in one region. Due to large population, it helps in faster recruitment of the patients, and retention of the participants in the trials on the higher side; thereby helping the companies to conduct the trials on the timely basis.
The financial targets and global competition are forcing the pharmaceutical players to look out for various options to introduce novel therapies in the market. At the same time, emerging shortage of clinical resources such as lack of naïve disease population, well trained labor, and sound medical infrastructure are delaying the process to initiate trials. Hence, all these companies are considering Latin America as an alternative option for conducting clinical trials.
The key players (Clinical Research Organizations) in the market include Chiltern, Omnicare, PPD, Parexel, Kendle, and Quintles.
The global clinical trials conducted in 2008 were reported to be 10,326 and were highest from 2007 to 2010. Oncology trials were the most widely conducted clinical trials accounting for 28.47% of all the trials conducted for the year 2008. Asia reported to a steady growth as compared to the other regions; which showed decline in the total number of clinical trials in the year 2010.
Scope of the report
Global clinical trials market research report categorizes by phases, by the study design, by the disease indications and with analysis of the geographic trends of conducting the clinical trials.
Clinical trials market by phases:
- Phase I
- Phase II
- Phase III
- Interventional trials
- Observational trials
- Expanded Access trials.
- Blood disorders
- Mental disorders
- North America
- South America
In addition, the report also provides 19 company profiles of the CROs covering the services and geographic presence.
Latest Market Research Reports:
- The Latino Household Products Shopper
- Omega-3: Global Product Trends and Opportunities
- Sugar, Sugar Substitute, and Sweetener Trends in the U.S., 3rd Edition
- Mobile Commerce in LTE: The Future of Commerce in 4G and Beyond
- Global Fetal (Labor & Delivery) and Neonatal Care Equipment Market (2011-2016)
- WiMAX-TDD/FDD Spectrum Analysis and Global Forecast (2011-2016)
- Global and China PV Ribbon Industry ( 2011 Deep Research Report )
- Publishing for the PreK-12 Market 2011-2012
ReportsnReports is an online library of over 75,000 market research reports and in-depth market research studies & analysis of over 5000 micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.
Follow us on Twitter: http://twitter.com/marketsreports
Our Facebook Page: http://www.facebook.com/pages/ReportsnReports/191441427571689
7557 Rambler road,
Suite 727, Dallas, TX 75231
Tel: + 1 888 391 5441
Visit Our Market Research Blog